Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002524.SZ Stock Summary
Top 10 Correlated ETFs
002524.SZ
In the News
002524.SZ Financial details
Company Rating
Buy
Market Cap
2.61B
Income
-199.93M
Revenue
1.02B
Book val./share
0.56
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
1.63K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
-16.79
Forward P/E
-
PEG
0.25
P/S
3.15
P/B
11.83
P/C
476
P/FCF
-12.73
Quick Ratio
0.36
Current Ratio
0.42
Debt / Equity
3.11
LT Debt / Equity
1.78
-
-
EPS (TTM)
-0.4
EPS next Y
-
EPS next Q
-
EPS this Y
-328.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.3%
Revenue last 5Y
-8.17%
Revenue Q/Q
-15.03%
EPS Q/Q
-70.18%
-
-
-
-
SMA20
-
SMA50
-16.67%
SMA100
-28.57%
Inst Own
-
Inst Trans
-
ROA
-13%
ROE
-72%
ROC
-0.24%
Gross Margin
31%
Oper. Margin
-19%
Profit Margin
-20%
Payout
-7%
Shs Outstand
509.42M
Shs Float
376.54M
-
-
-
-
Target Price
-
52W Range
3.36-7.79
52W High
-32%
52W Low
+58.67%
RSI
49
Rel Volume
0.91
Avg Volume
8.31M
Volume
7.59M
Perf Week
-4.23%
Perf Month
22.37%
Perf Quarter
-
Perf Half Y
-30.41%
-
-
-
-
Beta
0.533
-
-
Volatility
0.21%, 0.24%
Prev Close
0.63%
Price
4.76
Change
3.25%
002524.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.36 | 2.55 | 1.73 | 2.08 | 1.53 | |
Net income per share | -0.15 | 0.31 | 0.06 | 0.07 | -0.16 | |
Operating cash flow per share | 0.64 | 0.16 | 0.29 | 0.29 | 0.25 | |
Free cash flow per share | 0.55 | 0.07 | 0.17 | 0.18 | 0.17 | |
Cash per share | 1.07 | 0.3 | 0.22 | 0.18 | -0.01 | |
Book value per share | 1.63 | 1.76 | 0.61 | 0.68 | 0.54 | |
Tangible book value per share | 0.76 | 0.77 | -0.52 | -0.46 | -0.28 | |
Share holders equity per share | 1.63 | 1.76 | 0.61 | 0.68 | 0.54 | |
Interest debt per share | 1.56 | 0.6 | 0.91 | 1.66 | 1.69 | |
Market cap | 2.29B | 5.24B | 7.65B | 4.61B | 3.58B | |
Enterprise value | 2.61B | 5.27B | 7.96B | 5.35B | 4.33B | |
P/E ratio | -30.6 | 33.38 | 238.21 | 124.85 | -46.05 | |
Price to sales ratio | 1.95 | 4.08 | 8.3 | 4.41 | 4.67 | |
POCF ratio | 7.13 | 66.35 | 49.33 | 31.71 | 28.82 | |
PFCF ratio | 8.29 | 148.21 | 82.3 | 49.62 | 42.85 | |
P/B Ratio | 2.82 | 5.9 | 23.53 | 13.54 | 13.12 | |
PTB ratio | 2.82 | 5.9 | 23.53 | 13.54 | 13.12 | |
EV to sales | 2.22 | 4.1 | 8.64 | 5.12 | 5.64 | |
Enterprise value over EBITDA | 13.66 | 13.34 | 49.95 | 29.16 | 21.78 | |
EV to operating cash flow | 8.14 | 66.68 | 51.33 | 36.78 | 34.8 | |
EV to free cash flow | 9.46 | 148.94 | 85.63 | 57.55 | 51.75 | |
Earnings yield | -0.03 | 0.03 | 0 | 0.01 | -0.02 | |
Free cash flow yield | 0.12 | 0.01 | 0.01 | 0.02 | 0.02 | |
Debt to equity | 0.91 | 0.3 | 1.42 | 2.33 | 2.97 | |
Debt to assets | 0.28 | 0.15 | 0.31 | 0.43 | 0.52 | |
Net debt to EBITDA | 1.69 | 0.07 | 1.94 | 4.02 | 3.75 | |
Current ratio | 0.71 | 0.99 | 0.45 | 0.35 | 0.33 | |
Interest coverage | -0.53 | 9.58 | 3.66 | 2.04 | 2.71 | |
Income quality | -6.38 | 0.5 | 4.83 | 3.99 | -1.6 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0 | 0 | |
Payout ratio | -0.6 | 0.2 | 1.45 | 0.45 | -0.15 | |
Sales general and administrative to revenue | 0.05 | 0.04 | 0.05 | 0.04 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.3 | 0.38 | 0.41 | 0.31 | 0.27 | |
Capex to operating cash flow | -0.14 | -0.55 | -0.4 | -0.36 | -0.33 | |
Capex to revenue | -0.04 | -0.03 | -0.07 | -0.05 | -0.05 | |
Capex to depreciation | -0.46 | -0.44 | -0.99 | -0.49 | -0.41 | |
Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 2.34 | 3.52 | 0.91 | 1.06 | 1.38 | |
ROIC | -0.02 | 0.19 | 0.05 | 0.04 | 0.07 | |
Return on tangible assets | -0.04 | 0.14 | 0.04 | 0.03 | -0.07 | |
Graham Net | -1.36 | -0.73 | -1.64 | -2.44 | -2.29 | |
Working capital | -342.73M | -6.23M | -486.8M | -639.68M | -544.6M | |
Tangible asset value | 377.83M | 385.2M | -279.26M | -231.43M | -140.74M | |
Net current asset value | -672.27M | -174.15M | -752.98M | -1.15B | -1.01B | |
Invested capital | 0.91 | 0.3 | 1.42 | 2.33 | 2.97 | |
Average receivables | 272.6M | 272.55M | 197.09M | 181.41M | 167.79M | |
Average payables | 304.37M | 309.24M | 245.26M | 259.4M | 269.16M | |
Average inventory | 74.58M | 76.23M | 70.36M | 61.95M | 55.28M | |
Days sales outstanding | 99.88 | 63.49 | 67.65 | 67.13 | 68.24 | |
Days payables outstanding | 168.56 | 106.91 | 154.17 | 135.26 | 174.6 | |
Days of inventory on hand | 36.18 | 31.93 | 42.57 | 27.4 | 36.34 | |
Receivables turnover | 3.65 | 5.75 | 5.4 | 5.44 | 5.35 | |
Payables turnover | 2.17 | 3.41 | 2.37 | 2.7 | 2.09 | |
Inventory turnover | 10.09 | 11.43 | 8.57 | 13.32 | 10.04 | |
ROE | -0.09 | 0.18 | 0.1 | 0.11 | -0.28 | |
Capex per share | -0.09 | -0.09 | -0.12 | -0.1 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.46 | 0.39 | 0.55 | 0.84 | 0.55 | |
Net income per share | 0.39 | -0.42 | -0.02 | 0.03 | 0.01 | |
Operating cash flow per share | 0.39 | -0.42 | -0.02 | 0 | 0.06 | |
Free cash flow per share | 0.36 | -0.45 | -0.03 | -0.01 | 0.04 | |
Cash per share | 0.09 | -0.01 | 0 | 0.01 | 0.01 | |
Book value per share | 0.96 | 0.54 | 0.68 | 0.73 | 0.56 | |
Tangible book value per share | -0.14 | -0.28 | -0.38 | -0.33 | -0.26 | |
Share holders equity per share | 0.96 | 0.54 | 0.68 | 0.73 | 0.56 | |
Interest debt per share | 1.63 | 1.63 | 2.15 | 2.27 | 1.75 | |
Market cap | 3.32B | 3.58B | 2.91B | 2.4B | 3.52B | |
Enterprise value | 4.01B | 4.33B | 3.67B | 3.21B | 4.33B | |
P/E ratio | 4.23 | -4.25 | -99.45 | 46.11 | 167.19 | |
Price to sales ratio | 14.36 | 18.36 | 13.46 | 7.28 | 12.55 | |
POCF ratio | 16.93 | -16.99 | -397.81 | -3.59K | 110.54 | |
PFCF ratio | 18.35 | -15.72 | -247.72 | -514.61 | 155.45 | |
P/B Ratio | 6.86 | 13.12 | 10.96 | 8.34 | 12.41 | |
PTB ratio | 6.86 | 13.12 | 10.96 | 8.34 | 12.41 | |
EV to sales | 17.36 | 22.17 | 16.97 | 9.71 | 15.44 | |
Enterprise value over EBITDA | 19.51 | -71.81 | 1.36K | 168.82 | 261.04 | |
EV to operating cash flow | 20.46 | -20.52 | -501.53 | -4.79K | 135.94 | |
EV to free cash flow | 22.18 | -18.99 | -312.31 | -686.73 | 191.17 | |
Earnings yield | 0.06 | -0.06 | 0 | 0.01 | 0 | |
Free cash flow yield | 0.05 | -0.06 | 0 | 0 | 0.01 | |
Debt to equity | 1.67 | 2.97 | 3.15 | 3.06 | 3.11 | |
Debt to assets | 0.45 | 0.52 | 0.54 | 0.56 | 0.57 | |
Net debt to EBITDA | 3.37 | -12.35 | 281.43 | 42.31 | 48.78 | |
Current ratio | 0.44 | 0.33 | 0.35 | 0.43 | 0.42 | |
Interest coverage | -1.57 | -20.33 | -0.69 | 1.41 | 0.78 | |
Income quality | 1 | 1 | 1 | -0.05 | 6.05 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.01 | -0.01 | -0.39 | 0.24 | 0.89 | |
Sales general and administrative to revenue | 0.36 | -0.31 | 0.14 | -0.05 | 0.31 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.31 | 0.27 | 0.27 | 0.27 | 0.27 | |
Capex to operating cash flow | -0.08 | 0.08 | 0.61 | 5.97 | -0.29 | |
Capex to revenue | -0.07 | -0.09 | -0.02 | -0.01 | -0.03 | |
Capex to depreciation | -0.56 | -0.62 | -0.17 | -0.15 | 0.18 | |
Stock based compensation to revenue | -0.01 | 0.01 | 0 | 0 | 0 | |
Graham number | 2.91 | 2.27 | 0.53 | 0.74 | 0.36 | |
ROIC | -0.01 | -0.14 | 0 | 0.01 | 0 | |
Return on tangible assets | 0.16 | -0.18 | -0.01 | 0.01 | 0 | |
Graham Net | -2.21 | -2.29 | -2.89 | -2.8 | -2.16 | |
Working capital | -450.73M | -544.6M | -523.94M | -424.48M | -436.77M | |
Tangible asset value | -68.59M | -140.74M | -147.64M | -127.63M | -131.58M | |
Net current asset value | -961.28M | -1.01B | -992.24M | -951.8M | -952.25M | |
Invested capital | 1.67 | 2.97 | 3.15 | 3.06 | 3.11 | |
Average receivables | 151.76M | 155.42M | 148.17M | 175.76M | 199.15M | |
Average payables | 235.75M | 261.47M | 269.49M | 265.72M | 269.24M | |
Average inventory | 67.51M | 61.51M | 53.3M | 46.09M | 41.14M | |
Days sales outstanding | 65.23 | 66.16 | 63.59 | 54.17 | 64.08 | |
Days payables outstanding | 139.72 | 158.71 | 167.98 | 109.88 | 129.08 | |
Days of inventory on hand | 37.09 | 33.03 | 31.41 | 17.59 | 18.79 | |
Receivables turnover | 1.38 | 1.36 | 1.42 | 1.66 | 1.4 | |
Payables turnover | 0.64 | 0.57 | 0.54 | 0.82 | 0.7 | |
Inventory turnover | 2.43 | 2.72 | 2.87 | 5.12 | 4.79 | |
ROE | 0.4 | -0.77 | -0.03 | 0.05 | 0.02 | |
Capex per share | -0.03 | -0.03 | -0.01 | -0.01 | -0.02 |
002524.SZ Frequently Asked Questions
What is Guangzheng Eye Hospital Group Co., Ltd. stock symbol ?
Guangzheng Eye Hospital Group Co., Ltd. is a CN stock and trading under the symbol 002524.SZ
What is Guangzheng Eye Hospital Group Co., Ltd. stock quote today ?
Guangzheng Eye Hospital Group Co., Ltd. stock price is $4.76 today.
Is Guangzheng Eye Hospital Group Co., Ltd. stock public?
Yes, Guangzheng Eye Hospital Group Co., Ltd. is a publicly traded company.